Gennao Bio has a total of 76 patents globally, none of which have been granted. Of these 76 patents, more than 82% patents are active. Europe (EPO) is where Gennao Bio has filed the maximum number of patents, followed by United States of America and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Gennao Bio.
Gennao Bio founded in 2020, Gennao Bio is a private genetic medicines company developing targeted nucleic acid therapeutics using its proprietary GMAB (gene monoclonal antibody) platform. This novel, non-viral delivery system uses cell-penetrating antibodies to transport various nucleic acid payloads, like mRNA, siRNA, DNA, and gene-editing tools, directly to specific cells. Unlike traditional delivery methods, GMAB enables repeat dosing and scalable manufacturing. Gennao Bio is initially focusing on oncology and rare skeletal muscle diseases.
Do read about some of the most popular patents of Gennao Bio which have been covered by us in this article and also you can find Gennao Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Gennao Bio patent portfolio.
How many patents does Gennao Bio have?
Gennao Bio has a total of 76 patents globally. These patents belong to 11 unique patent families. Out of 76 patents, 62 patents are active.
How Many Patents did Gennao Bio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Gennao Bio Applications Filed | Gennao Bio Patents Granted |
| 2025 | – | – |
| 2024 | 9 | – |
| 2023 | 23 | – |
| 2022 | 24 | – |
| 2021 | 20 | – |
How many Gennao Bio patents are Alive/Dead?
Worldwide Patents
How Many Patents did Gennao Bio File in Different Countries?
Countries in which Gennao Bio Filed Patents
| Country | Patents |
| Europe (EPO) | 8 |
| United States of America | 7 |
| China | 6 |
| Japan | 6 |
| Australia | 6 |
| Korea (South) | 5 |
| Israel | 5 |
| Canada | 5 |
| Brazil | 3 |
| Mexico | 3 |
| Hong Kong (S.A.R.) | 3 |
| New Zealand | 2 |
| India | 1 |
| Singapore | 1 |
| Argentina | 1 |
| Taiwan | 1 |
Where are Research Centres of Gennao Bio Patents Located?
All Research centers of Gennao Bio are in the United States of America.
Best Patents of Gennao Bio
WO2023168427A1 is the most popular patent in the Gennao Bio portfolio. It has received 11 citations so far from company like Dyne Therapeutics.
Below is the list of most cited patents of Gennao Bio:
| Publication Number | Citation Count |
| WO2023168427A1 | 11 |
| WO2023168352A1 | 5 |
| WO2022120276A1 | 5 |
| US20230303719A1 | 2 |
| WO2023034864A1 | 2 |
| US20230265214A1 | 1 |
| WO2022187549A1 | 1 |
What Percentage of Gennao Bio US Patent Applications were Granted?
Gennao Bio (Excluding its subsidiaries) has filed 6 patent applications at USPTO so far (Excluding Design and PCT applications). None have been granted leading to a grant rate of 0%.
Below are the key stats of Gennao Bio patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Gennao Bio?
| Law Firm | Total Applications | Success Rate |
| Morgan Lewis & Bockius Llp | 6 | 0% |
What are Gennao Bio key innovation segments?
What Technologies are Covered by Gennao Bio?
The chart below distributes patents filed by Gennao Bio in different countries on the basis of the technology protected in patents. It also represents the markets where Gennao Bio thinks it’s important to protect particular technological inventions.
R&D Focus: How has Gennao Bio search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Gennao Bio?
